Detecting conversion from mild cognitive impairment to Alzheimer’s disease using FLAIR MRI biomarkers

Mild cognitive impairment (MCI) is the prodromal phase of Alzheimer’s disease (AD) and while it presents as an imperative intervention window, it is difficult to detect which subjects convert to AD (cMCI) and which ones remain stable (sMCI). The objective of this work was to investigate fluid-attenu...

Descripción completa

Detalles Bibliográficos
Autores principales: Crystal, Owen, Maralani, Pejman J., Black, Sandra, Fischer, Corinne, Moody, Alan R., Khademi, April
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666029/
https://www.ncbi.nlm.nih.gov/pubmed/37952286
http://dx.doi.org/10.1016/j.nicl.2023.103533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666029/
https://www.ncbi.nlm.nih.gov/pubmed/37952286
http://dx.doi.org/10.1016/j.nicl.2023.103533

Ejemplares similares